Pregna-1,4-diene-3,20-dione,9-fluoro-11,17-dihydroxy-16-methyl-21-[(4-pyridinylcarbonyl)oxy]-, (11b,16a)- cas no:2265-64-7
Synonyms: Pregna-1,4-diene-3,20-dione,9-fluoro-11b,17,21-trihydroxy-16a-methyl-, 21-isonicotinate(7CI,8CI);Ausixone;Auxiloson;Dexamethasone 21-(4-pyridinecarboxylate);Dexamethasone 21-isonicotinate;Dexamethasone isonicotinate;HE 111;Isonicotinic acid dexamethasone-21 ester;Isonicotinic acid, 21-ester with 9-fluoro-11b,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione;Ketoren;Pyridine-4-carboxylic acid 21-dexamethasone ester;Pyridine-4-carboxylic acid-(dexamethasone-21')-ester;Voren;
NamePregna-1,4-diene-3,20-dione,9-fluoro-11,17-dihydroxy-16-methyl-21-[(4-pyridinylcarbonyl)oxy]-, (11b,16a)-
CAS2265-64-7
SynonymsPregna-1,4-diene-3,20-dione,9-fluoro-11b,17,21-trihydroxy-16a-methyl-, 21-isonicotinate(7CI,8CI);Ausixone;Auxiloson;Dexamethasone 21-(4-pyridinecarboxylate);Dexamethasone 21-isonicotinate;Dexamethasone isonicotinate;HE 111;Isonicotinic acid dexamethasone-21 ester;Isonicotinic acid, 21-ester with 9-fluoro-11b,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione;Ketoren;Pyridine-4-carboxylic acid 21-dexamethasone ester;Pyridine-4-carboxylic acid-(dexamethasone-21')-ester;Voren;
EINECS(EC#)218-866-5
Molecular FormulaC28H32 F N O6
Molecular Weight497.5552
refractive index1.608
Safety
Moderately toxic by intraperitoneal route. Experimental reproductive effects. A steroid. When heated to decomposition it emits toxic fumes of F− and NOx.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
281mg/kg (281mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |
mouse |
LD50 |
oral |
3470mg/kg (3470mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |
mouse |
LD50 |
subcutaneous |
3211mg/kg (3211mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |
rat |
LD50 |
intraperitoneal |
313mg/kg (313mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |
rat |
LD50 |
oral |
3562mg/kg (3562mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |
rat |
LD50 |
subcutaneous |
3297mg/kg (3297mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: ATAXIA |
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 20, Pg. 769, 1973. |